Faced with the globalization of drug production, the United States is joining with Europe and Australia to inspect factories in countries such as China and India that make an increasing share of the active ingredients in medications. Bush administration officials said Wednesday that the agreement would allow regulators to coordinate their inspections and share information, thereby covering a wider territory and more foreign facilities. Full Story
About OODA Analyst
OODA is comprised of a unique team of international experts capable of providing advanced intelligence and analysis, strategy and planning support, risk and threat management, training, decision support, crisis response, and security services to global corporations and governments.